Advisor Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$219K Buy
10,171
+851
+9% +$19.1K ﹤0.01% 2332
2019
Q3
$213K Buy
9,320
+2,317
+33% +$49.4K ﹤0.01% 2276
2019
Q2
$137K Buy
7,003
+2,793
+66% +$54.4K ﹤0.01% 2620
2019
Q1
$82K Sell
4,210
-1,875
-31% -$35.5K ﹤0.01% 3026
2018
Q4
$100K Sell
6,085
-1,123
-16% -$22.6K ﹤0.01% 2658
2018
Q3
$166K Buy
7,208
+2,226
+45% +$50.4K ﹤0.01% 2332
2018
Q2
$108K Sell
4,982
-1,810
-27% -$35.4K ﹤0.01% 2468
2018
Q1
$120K Sell
6,792
-6,225
-48% -$110K ﹤0.01% 2411
2017
Q4
$245K Sell
13,017
-2,020
-13% -$40.2K ﹤0.01% 1829
2017
Q3
$330K Buy
15,037
+14,710
+4,498% +$332K 0.01% 1468
2017
Q2
$8K Buy
327
+117
+56% +$2.98K ﹤0.01% 4048
2017
Q1
$6K Buy
210
+88
+72% +$2.31K ﹤0.01% 4044
2016
Q4
$3K Buy
122
+76
+165% +$1.74K ﹤0.01% 4131
2016
Q3
$1K Sell
46
-124
-73% -$2.97K ﹤0.01% 4344
2016
Q2
$3K Buy
+170
New +$3.54K ﹤0.01% 3996

Other funds holding SBRA

Advisor Group's SBRA Position: Q4 2019 in Review

Advisor Group increased its Sabra Healthcare REIT (SBRA) stake by 9.1% in Q4 2019, buying an estimated $19.1K and bringing the position to 10,171 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #2332.

Advisor Group first reported a position in SBRA in Q2 2016 and has held it in 15 quarters since. The position peaked at $330K in Q3 2017. 374 funds tracked by Wall St. Rank hold SBRA as of Q4 2019.

  • Advisor Group held 10,171 shares of Sabra Healthcare REIT worth $219K as of Q4 2019.
  • Advisor Group bought 851 Sabra Healthcare REIT shares in Q4 2019, an estimated $19.1K.
  • Sabra Healthcare REIT made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2332 holding.
  • Advisor Group first reported a position in Sabra Healthcare REIT in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Sabra Healthcare REIT position peaked at $330K in Q3 2017.
  • 374 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.